ParcelBio co-founders Chris Carlson (L) and David Weinberg May 6, 2026 11:17 AM EDT R&DCell/Gene Tx Exclusive: Startup aims to lift mRNA out of purgatory with more durable therapies Ryan Cross Senior Science Correspondent Two scientists think they’ve solved a technical problem that has kept the mRNA revolution from reaching its full potential. Now, they’re launching ParcelBio with $13 … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
endpoints· 2mo ago
saveFormer Orbital scientists launch new mRNA therapy startup
May 6, 2026read original ↗
Two scientists think they've solved a technical problem that has kept the mRNA revolution from reaching its full potential. Now, they're launching ParcelBio with $13 million in seed funding to develop drugs based on their ...
94 words · extracted 2mo agoread original ↗
🔗 mentioned in this article
no entities indexed yet
comments(0)
5-min edit window · permanent after that